Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, will ...

Scientists comment on a UK Health Security Agency (UKHSA) announcement that a new mpox strain has been identified in England. Dr Jonas Albarnaz, Institute Fellow, Capripoxvirus Biology, Pirbright ...

In the dim waters off the Japanese coast, scientists have stumbled upon something that shouldn’t exist. Or at least not by ...

Scientists trace the origins of human kissing back over 20 million years to ancient apes who first showed gentle ...

Apple TV's Pluribus is the new incredible sci-fi show on the block. For fans of the series, here are 15 other shows to binge ...

A retrospective real-world analysis presented at the 2025 ASH Annual Meeting and Exposition showed that circulating tumor DNA (ctDNA) detected at the end of treatment (EOT) was a prognostic indicator ...

Dr Ryan Magee graduates today with a PhD in Biological Sciences, having developed a faster, cheaper method to track a major ...

RRS Sir David Attenborough scientists are trying to measure the potentially crucial role of ocean manganese, finds. But how ...

Many medical advancements have come at the cost of rodent lives, and that's largely due to some rather surprising ...

This article is all about what’s new and what it might mean for us, covering the latest in genetics in news. New methods like ...

At the meeting, researchers shared real-world data showing ctDNA positivity at the end of treatment was prognostic across lymphoma subtypes and better than PET scans.